19.11.2007 13:00:00
|
Cognex In-Sight Vision Sensors Selected by NEXUS Biosystems
Cognex Corporation (NASDAQ: CGNX) announced today that NEXUS Biosystems,
a developer of automation systems for the pharmaceutical and biotech
industry, will integrate Cognex’s In-Sight®
5603 vision sensor into its Universal Store®
system. The Universal Store is an automated system used in the biotech
and pharmaceutical industries for managing hundreds of thousands to
millions of laboratory samples and compounds.
The In-Sight vision sensors will be used to read data matrix codes
etched on each sample vial. The codes enable the Universal Store system
to automatically store and then retrieve individual vials when those
samples are required for testing.
"We selected In-Sight for this application
because speed and accuracy are critical,” said
John Lillig, President and CEO of NEXUS Biosystems. "In-Sight
can read an entire tray of up to 96 vials at once with 100 percent
accuracy, which enables us to facilitate quick identification, storage
and retrieval of large quantities of samples.” "This is a significant win for Cognex for two
important reasons,” said Dr. Robert J.
Shillman, Chairman and CEO of Cognex. "First,
because of its size.... we expect bookings to total near the mid-six
figures...and second, because the application represents an entirely new
and very promising market for Cognex vision.”
Cognex In-Sight 5600 series vision sensors are the fastest on the
market, helping manufacturers achieve significant improvements in
productivity, quality and cost reduction. The 5603 model adds the
highest resolution (1600 X 1200 pixels) available in the In-Sight
product line, and offers a full library of vision tools for guidance,
inspection, gauging, as well as identification.
About NEXUS Biosystems, Inc.
NEXUS Biosystems, a privately held company based in Poway, California,
USA, has since 1996 been a developer and provider of enabling
technologies and automation systems for pharmaceutical, biotech,
agrochemical and academic research institutions worldwide. Current
products include the Universal Store® and
Universal LabStore® family of next generation
sample storage and retrieval systems, the Crystal Farm®
line of protein crystallization systems, and the IRORI®
line of chemical synthesis technologies and services. More information
is available at www.nexusbio.com.
About Cognex
Cognex Corporation designs, develops, manufactures and markets machine
vision sensors and systems, or devices that can "see." Cognex vision
sensors are used in factories around the world to automate the
manufacture of a wide range of items and to assure their quality. Cognex
is the world's leader in the machine vision industry, having shipped
more than 400,000 machine vision systems, representing over $2 billion
in cumulative revenue, since the company's founding in 1981. In addition
it its corporate headquarters in Natick, Massachusetts, Cognex also has
regional offices and distributors located throughout North America,
Japan, Europe, Asia and Latin America. Visit Cognex on-line at http://www.cognex.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Cognex Corp.mehr Nachrichten
Analysen zu Cognex Corp.mehr Analysen
Aktien in diesem Artikel
Cognex Corp. | 38,31 | -0,67% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 954,30 | -0,50% | |
S&P 600 SmallCap | 935,46 | -0,94% |